These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6884200)

  • 21. [The value of electrophysiological studies in the treatment of ventricular tachycardias with amiodarone alone or in combination with class-I anti-arrhythmia drugs].
    Bellocci F; Santarelli P; Montenero S; Nobile A; Spampinato A; Nava S; Zecchi P; Manzoli U
    Cardiologia; 1988 Apr; 33(4):399-405. PubMed ID: 3409264
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anti-arrhythmia therapy in transition?].
    Internist (Berl); 1990 Mar; 31(3 Suppl [ Anniv No TIARRH):2. PubMed ID: 2351532
    [No Abstract]   [Full Text] [Related]  

  • 23. [New approach to therapy of various paroxysmal disorders of cardiac rhythm].
    Berezin FB; Bogoslovskiĭ VA
    Ter Arkh; 1976; 48(10):44-8. PubMed ID: 1024276
    [No Abstract]   [Full Text] [Related]  

  • 24. Approaches to Controlling Cardiac Arrhythmias: Focus on Amiodarone, the Last 15 Years. Proceedings of a symposium. Dallas, Texas, USA. November 7, 1998.
    Am J Cardiol; 1999 Nov; 84(9A):1R-173R. PubMed ID: 10610617
    [No Abstract]   [Full Text] [Related]  

  • 25. [Peculiarities of anti-arrhythmia treatment of heart failure].
    Klein G
    Internist (Berl); 1990 Mar; 31(3 Suppl [ Anniv No TIARRH):6-8. PubMed ID: 2351533
    [No Abstract]   [Full Text] [Related]  

  • 26. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Gambhir DS
    Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of arrhythmias in hypertrophic cardiomyopathy].
    Rapezzi C; Spirito P
    G Ital Cardiol; 1995 Nov; 25(11):1443-6. PubMed ID: 8682242
    [No Abstract]   [Full Text] [Related]  

  • 28. [Harmful interactions of amiodarone and class I anti-arrhythmia agents].
    Tartini R; Kappenberger L; Steinbrunn W
    Schweiz Med Wochenschr; 1982 Nov; 112(45):1585-7. PubMed ID: 7156952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limitations of present drug therapy of cardiac arrhythmias--a review.
    Jewitt DE
    Postgrad Med J; 1977; 53 Suppl 1():12-21. PubMed ID: 17855
    [No Abstract]   [Full Text] [Related]  

  • 30. [Worsening of ventricular arrhythmia in the dynamic ECG in patients treated with anti-arrhythmia drugs].
    Lanza GA; Tamburi S; Mondello Malvestiti FM; Rebuzzi AG; Lucente M
    Cardiologia; 1988 Jun; 33(6):613-8. PubMed ID: 3139292
    [No Abstract]   [Full Text] [Related]  

  • 31. Amiodarone for the emergency care of children.
    Lane RD; Nguyen KT; Niemann JT; Bolte RG; Etheridge SP; Gausche-Hill M
    Pediatr Emerg Care; 2010 May; 26(5):382-9. PubMed ID: 20453797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arrhythmia as risk factor].
    Internist (Berl); 1997 Feb; 38(2 Suppl Risikofakt):1-8. PubMed ID: 9330651
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of heart rhythm disorders].
    Lüderitz B
    Dtsch Med Wochenschr; 1990 Dec; 115(51-52):1980. PubMed ID: 2261864
    [No Abstract]   [Full Text] [Related]  

  • 34. [Long-term clinical trial of amiodarone chlorhydrate as an antiarrhythmia agent].
    Simeoni L; Guerra G; Piva M
    Clin Ter; 1976 Sep; 78(6):537-58. PubMed ID: 797507
    [No Abstract]   [Full Text] [Related]  

  • 35. [Anti-arrhythmia treatment (clinical problems, classification of anti-arrhythmia drugs and personal experience].
    Walczak F
    Kardiol Pol; 1992; 36(2):97-104. PubMed ID: 1583833
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experience with the combined use of 1st- and 2d-group anti-arrhythmic preparations in patients with refractory arrhythmia].
    Abdalla A; Mazur NA
    Klin Med (Mosk); 1988 Jun; 66(6):40-3. PubMed ID: 2460667
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiarrhythmic therapy in the post-infarction setting: update from major amiodarone studies.
    Cairns JA
    Int J Clin Pract; 1998 Sep; 52(6):422-4. PubMed ID: 9894381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Living with amiodarone. The story behind this effective heart-rhythm drug, the way it acts in the body, and even its side effects are on the strange side. Understanding its idiosyncrasies can help you use it safely.
    Harv Heart Lett; 2003 Oct; 14(2):3. PubMed ID: 14576034
    [No Abstract]   [Full Text] [Related]  

  • 39. New approaches to antiarrhythmic therapy.
    Zipes DP
    N Engl J Med; 1981 Feb; 304(8):475-6. PubMed ID: 7453773
    [No Abstract]   [Full Text] [Related]  

  • 40. Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter.
    Hauser TH; Pinto DS; Josephson ME; Zimetbaum P
    Am J Cardiol; 2004 May; 93(9):1173-6. PubMed ID: 15110217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.